Skip to main content
. 2015 Dec 19;7(3):2754–2764. doi: 10.18632/oncotarget.6666

Table 4. Diagnostic significance of POU4F2, C1, C2, and C3 in the training and validation sets together.

Gene Sensitivity, % (pos./total) Specificity, % (neg./total) PPVa, % (true pos./total pos.) NPVb, % (true neg./total neg.)
POU4F2 90.00% (117/130) 92.86% (169/182) 90.00% (117/130) 92.86% (169/182)
C1 92.31% (120/130) 89.56% (163/182) 86.33% (120/139) 94.22% (163/173)
C2 90.00% (117/130) 93.96% (171/182) 91.41% (117/128) 92.93% (171/184)
C3 94.62% (123/130) 81.32% (148/182) 78.34% (123/157) 95.48% (148/155)
a

Positive predictive value.

b

Negative predictive value.